Atazor 300 mg Capsule
Regulated Product — Business License RequiredB2B and export product information for licensed and authorized business customers. Contact our team regarding bulk supply, documentation, and applicable commercial, import, and export requirements. This page is not a storefront and no purchasing, checkout, or pricing is offered here.
Product Overview
Atazor 300 mg Capsule contains atazanavir, an HIV-1 protease inhibitor. Its labelling describes it for the treatment of HIV infection, used in combination with other antiretroviral medicines and generally boosted with low-dose ritonavir. It is described as taken with food at the same time each day, with the treatment course completed as directed by the prescriber.
Product Information
The following description reflects information associated with atazanavir and this product’s labelling. It has not been independently clinically verified by SDO Pharma and is provided for business and product-identification purposes only. It is not medical advice and does not replace the manufacturer’s official prescribing information.
Described Uses
- Described for the treatment of HIV infection as part of combination antiretroviral therapy
- Described as generally boosted with low-dose ritonavir, per prescribing information
- Described as interfering with an enzyme HIV needs to produce new virus particles
Described Dosage & Administration
- Taken by mouth with food, at about the same time each day, at the dose and duration set by the prescriber
- The prescriber’s instructions on dose and duration should be followed exactly
- The full treatment course should be completed, as stopping early is described as risking the infection worsening
- Doses should not be skipped, to maintain effective drug levels
Described Side Effects
Commonly described side effects include:
- Rash
- Headache
- Nausea, vomiting, and diarrhoea
- Cough
- Muscle pain
- Yellowing of the skin or eyes (jaundice) and raised bilirubin in the blood
- Fever
These are described as tending to settle on their own. More serious effects — including severe skin reactions and liver problems — are described as needing prompt medical attention.
Precautions
- The prescriber should be told about any allergy to antibiotics and about any kidney or liver problems
- Complete medical history should be shared with the prescriber before starting treatment
- Pregnant women and breastfeeding mothers should consult their doctor before starting treatment
- The capsule is described as taken with food; any persistent or severe side effect should be reviewed by a clinician
This summary is provided for informational purposes only and does not replace the manufacturer’s official product labelling or professional medical advice.
B2B, Import & Export Enquiries
SDO Pharma supports business enquiries for pharmaceutical products, including bulk and export supply, subject to applicable licensing, regulatory, import, and export requirements. Requirements vary according to the destination market and the nature of the transaction.
We do not claim that this product is available for import into every country, and we do not claim FDA, UAE, EU, or other specific regulatory approval unless independently verified. Applicable documentation — including a valid Drug License, tax registration, and Importer Exporter Code (IEC) where relevant — is discussed directly with our team as part of the enquiry process. This is a regulated / prescription-status product supplied only to licensed and authorized business customers; SDO Pharma does not sell it directly to individual patients or consumers. See our Regulated Products Policy.
Request Product Information
Interested in this product for your business? Submit your enquiry and our team will contact you regarding bulk supply, documentation, and applicable requirements.
Frequently Asked Questions
Per its labelling it contains atazanavir, an HIV-1 protease inhibitor used with other antiretroviral medicines to treat HIV infection, generally boosted with low-dose ritonavir. SDO Pharma has not independently verified the manufacturer’s claims and does not claim any specific regulatory approval unless independently confirmed.
Its labelling describes the capsule as taken by mouth with food, at about the same time each day, at the dose and duration set by the prescriber. The full course should be completed and doses should not be skipped.
Licensed and authorized business customers can submit the product enquiry form above or contact our team directly. Product availability, documentation, and supply arrangements are confirmed per enquiry.
Availability depends on the destination market’s regulatory requirements and cannot be confirmed without a direct enquiry. See our B2B, Import & Export Enquiries section above.
Related Product Categories
SDO Pharma works across several pharmaceutical and healthcare product categories for business customers.